NorthWest Biotherapeutics Inc (NWBO)

[highwayman4life]

But, patients who cross are analyzed as part of their originally randomized arm.

Or comparing early to late

You are on the right track if you are thinking that they ALL received care at leading research hospitals, ALL had complete or near complete resection often aided by intraoperative MRI, ALL were shown, via MRI, to be stable or better following their primary chemorad, ALL did not require heavy or even moderate doses of steroids, and of course, ALL had to meet special requirements for blood work.

I am thinking all those criteria would be taken into consideration by the lead trial investigator and not for armchair quarterbacks to speculate on. I am certain Dr Liau has a much better understanding of how to run a clinical trial than you might.